Physician profile
Loretta A Preston
NPI 1598776726
$9,624.65
in general payments reported to CMS, 2019-2025
10 companies · $1,265 in 2025
The $1,265 reported for 2025 was more than what 97% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $428 · 2022: $2,330 · 2023: $3,512 · 2024: $2,090 · 2025: $1,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,270 · Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,270.00 |
| Food and Beverage | $597.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $8,401.73 | 2022-2025 | Nexplanon |
| Abbvie INC. | $235.03 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $230.20 | 2021-2023 | Uzedy |
| Esperion Therapeutics, INC. | $125.00 | 2022 | |
| Axsome Therapeutics, INC. | $122.28 | 2025 | Auvelity |
| Merck Sharp & Dohme LLC | $114.05 | 2023 | Verquvo |
| Amgen INC. | $107.51 | 2023 | Repatha |
| Novo Nordisk INC | $106.61 | 2021 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $97.73 | 2025 | |
| Alnylam Pharmaceuticals INC. | $84.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loretta Preston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.